One big antibiotic dose fights MRSA, study says

Wall Street Journal (subscription required), October 22, 2008

Powerful antibiotic drugs are normally injected once a day—a problem for patients who contract infections in hospital wards and are sent home. But a new study found that an experimental antibiotic may work just as well when given in one gigantic dose, marking progress in the treatment of drug-resistant infections, including MRSA. The research was conducted by Targanta Therapeutics Corp., a company that has applied to sell the antibiotic, oritavancin, in the U.S.


MOST POPULAR

SPONSORED REPORTS
SPONSORED HEADLINES

SIGN UP

FREE e-Newsletters Join the Council Subscribe to HL magazine

SPONSORSHIP & ADVERTISING

100 Winners Circle Suite 300
Brentwood, TN 37027

800-727-5257

About | Advertise | Terms of Use | Privacy Policy | Reprints/Permissions | Contact
© HealthLeaders Media 2014 a division of BLR All rights reserved.